When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Wolff-Parkinson-White syndrome

Última revisão das evidências: 23 Mar 2026
Última atualização do tópico: 24 Sep 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • atrioventricular re-entrant tachycardia (AVRT)
Detalhes completos

Outros fatores diagnósticos

  • palpitations
  • dizziness
  • shortness of breath
  • chest pain
  • atrial fibrillation
  • atrial flutter
  • congenital cardiac abnormalities
  • sudden cardiac death
  • syncope and presyncope
  • tachycardia in pregnancy
Detalhes completos

Fatores de risco

  • Ebstein anomaly
  • hypertrophic cardiomyopathy
  • mitral valve prolapse
  • atrial septal defect
  • ventricular septal defect
  • transposition of great vessels
  • coarctation of aorta
  • dextrocardia
  • coronary sinus diverticula
  • right and left atrial aneurysms
  • cardiac rhabdomyomas
  • Marfan syndrome
  • Friedreich ataxia
  • family history
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • 12-lead ECG
Detalhes completos

Investigações a serem consideradas

  • echocardiogram
  • treadmill exercise test
  • electrophysiology study
Detalhes completos

Algoritmo de tratamento

Inicial

unstable: BP <90/60 mmHg, signs of systemic hypoperfusion or unstable atrial fibrillation

AGUDA

stable: narrow complex (orthodromic atrioventricular reciprocating) tachycardia

stable: wide complex (antidromic atrioventricular reciprocating) tachycardia

stable: pre-excited tachycardia due to atrial fibrillation or atrial flutter

stable: pre-excited tachycardia due to atrial tachycardia

CONTÍNUA

following acute treatment: asymptomatic

following acute treatment: symptomatic

Colaboradores

Autores

Hugh Calkins, MD

Professor of Medicine

Director of Electrophysiology

Johns Hopkins University School of Medicine

Baltimore

MD

Declarações

HC declares that he is a consultant for Medtronic, Biosense Webster, Abbott, and Boston Scientific.

Agradecimentos

We would like to acknowledge our cardiology expert panel member, Dr Fred Kusumoto, for his contribution to this topic.

Professor Hugh Calkins would like to gratefully acknowledge Dr David Frankel, Dr Mithilesh K. Das, and Dr Douglas P. Zipes, previous contributors to this topic.

Declarações

DF, MKD, and DPZ declare that they have no competing interests.

Revisores

Nicolas Palaskas, MD, FACC

Assistant Professor

University of Texas MD Anderson Cancer Center

Houston

TX

Declarações

NP declares that he has no competing interests.

Joseph E. Marine, MD

Associate Professor of Medicine

Director of Electrophysiology

Johns Hopkins University School of Medicine

Baltimore

MD

Declarações

JEM declares that he has no competing interests.

Suneet Mittal, MD

Director

Electrophysiology Laboratory

The St. Luke's-Roosevelt Hospital Center

New York

NY

Declarações

SM declares that he has no competing interests.

Andrew Turley, MB ChB

Cardiology Specialist Registrar

The James Cook University Hospital

Middlesbrough

UK

Declarações

AT declares that he has no competing interests.

Steve Hsu, MD

Associate Professor

Department of Medicine

Division of Cardiology

University of Florida College of Medicine

Jacksonville

FL

Declarações

SH declares that he has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.Texto completo  Resumo

Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126.Texto completo  Resumo

Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016 Apr 5;67(13):e27-115.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Wolff-Parkinson-White syndrome images
  • Diagnósticos diferenciais

    • Atriofascicular pathway
    • Lown-Ganong-Levine syndrome
    • Nodofascicular pathway
    Mais Diagnósticos diferenciais
  • Diretrizes

    • 2023 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation
    • 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Atrial fibrillation

    Mais Folhetos informativos para os pacientes
  • Videos

    Electrical (direct current) cardioversion animated demonstration

    Mais vídeos
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal